Disc Medicine (IRON) Stock Price, Quote, News & History | Benzinga

SPY769.46−0.47%QQQ719.45−0.79%BTC/USD82,097.99−2.29%DIA525.92−0.34%GLD378.00−0.25%TLT80.48+0.30%

Disc Medicine Inc (IRON) Stock Price, Quote, News & History

IRONNASDAQ

Trade with Public

Trade with Public

$76.00

-3.48-4.38%

Last update: Oct 21, 5:38 PM

$76.20

-3.28-4.13%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$76.00

Volume / Avg.

0 / 641.16K

Day Range

- - -

52 Wk Range

40.00 - 99.50

Market Cap

$2.93B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

22.08%

Days to Cover

12.79

Recent Disc Medicine, Inc. News

Amazon.com, Cleveland-Cliffs, Disc Medicine, Silence Therapeutics and EyePoint: Why These 5 Stocks Are on Investors' Radars Today

Major U.S. indices ended mixed on Monday, with the Dow Jones Industrial Average slipping 0.07% to 51,966.03.

Shivdeep Dhaliwal

Crude Oil Moves Higher; US Homebuilder Sentiment Falls In October

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Monday.The Dow traded up 0.06% to 52,031.59 while the NASDAQ jumped 1.24% to 26,465.39. The S&P 500 also

Avi Kapoor

Disc Medicine Delivers Promise For Patients with Sunlight Sensitivity In Successful Pivotal Study

Disc Medicine reports positive Phase 3 results for bitopertin in EPP, meeting all primary and secondary endpoints. NDA resubmission planned.

Vandana Singh

Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday

U.S. stocks mixed as Dow fell ~100 points; Silence Therapeutics surged 125.7% on Merck KGaA buyout, while biotech and tech shares gained.

Avi Kapoor

Stock Market Today: Dow Futures Drop, S&P 500, Nasdaq 100 Rise as Scott Bessent Links September Inflation to 'Energy Shock'— RCAT, ESLT, STLD in Focus (UPDATED)

U.S. stock futures were higher on Monday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Friday's lower close.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-197.54M

Investing Cash Flow (TTM)

-93.42M

Financing Cash Flow (TTM)

262.30M

Free Cash Flow (TTM)

-197.58M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-28.66M

Analyst Trends and Forecast

1

May

2

Jun

1

Aug

3

Sep

6

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.53

Earnings Yield % (TTM)

-8.68%

Earnings Yield % (FWD)

-8.52%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$16.78

Company Debt

Total Debt

$59.34M

LT Debt

$59.34M

LT Debt Issuance (TTM)

$29.98M

LT Debt Repayment (TTM)

-

Total Cash

$98.68M

Debt to Equity

0.09

Issuance of Debt (TTM)

$29.98M

Repayment of Debt (TTM)

-